On 11/6/24, Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) stock enjoyed a major increase of 12.2%, closing at $5.04. Moreover, unusually high trading volume at 196% of normal accompanied the advance. The stock has been extremely weak relative to the market over the last nine months but has risen 18.6% during the last week.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to fall short of the cost of capital, IRWD is expected to be a major Value Eraser.
Ironwood Pharmaceuticals is currently unrated.
Rating Review
The stock is currently unrated.
Be the first to comment